Here's your summary from Novo Nordisk Boss on Ozempic and Eating Disorder Criticism, Social Media Pressure (https://www.youtube.com/watch?v=-HMkpPhfltI) on the Bloomberg Television channel:

**TLDR:** Novo Nordisk focuses on educating physicians about their products for type two diabetes and obesity, trusting them to prescribe appropriately and not to patients with eating disorders.

1. Novo Nordisk focuses on educating physicians about their products for type two diabetes and obesity, ensuring they understand the mechanisms and appropriate patients.

2. The company acknowledges the concern that social media promotion of their products could lead to more eating disorders, but believes in trusting physicians to prescribe responsibly.

3. Novo Nordisk recognizes the limitations in controlling social media but emphasizes the importance of physician involvement in prescribing their medicines.

#finance #tradfi #markets #stocks #stockmarket #bloomberg #macro